In-Vitro and In-Silico Alpha Glucucosidase Inhibitory activity of Oroxylum indicum

• Published in: Research journal of pharmacognosy and phytochemistry Vol. 13; no. 3; pp. 119 - 125
• Main Authors: S., Gejalakshmi, N., Harikrishnan, Mohameid, Anas S.
• Format: Journal Article
• Language: English
• Published: Raipur A&V Publications 20.08.2021
• Subjects: Antioxidants; Cytotoxicity; Diabetes; Enzymes; Flavonoids; Free radicals; Glucose; Hyperglycemia; Insulin; Regression analysis
• ISSN: 0975-2331; 0975-4385
• DOI: 10.52711/0975-4385.2021.00020

Background: Diabetes mellitus is a metabolic condition characterized by elevated blood glucose levels in the bloodstream. It occurs due to the inadequate amount of insulin secreted in the body or resistance of insulin receptors. Objective: In the present study, for its effect on alpha-amylase and alpha-glucosidase enzymes, Oroxylum indicuma flavone glycoside was assessed using in-vitro assays by removing the respective enzymes from whole wheat and barley in conjunction with in-silico analysis. Method: in-vitro alpha amylase inhibitory activity and in-vitro alpha glucosidase inhibitory activity was performed using acarbose as a standard drug. The molecular docking study was performed using Schrodinger (Maestro V 11.5) software. The parameters glide score, Lipinski rule for drug likeliness, bioactive scoring and ADME properties were assessed in the docking study. In addition, baicalein's antioxidant function was assessed using DPPH assay, nitric oxide scavenging activity. The cytotoxicity of Oroxylum indicumwas evaluated using the Brine shrimp lethality assay. Results: The alpha-amylase assay performed showed IC50 value of 48.40 µg/ml for Oroxylum indicumwhereas alpha-glucosidase assay showed an IC50 value of 16.03 µg/ml. Oroxylum indicumshows the glide score of-5.565 with 5EOF and glide score of -5.339 with 5NN8 in the molecular docking study. The highest percentage of DPPH radical scavenging activity and nitrous oxide scavenging activity were found to be.27% at160 µg/ml and 50.02% at the concentrations of 160 µg/ml respectively. Conclusion: Based on further in vivo and clinical trials, Oroxylum indicummay be used for the management of hyperglycaemia.